Le Lézard
Classified in: Health
Subjects: LEG, AVO

The FEND Off Fentanyl Act Offers a Path Forward on Tackling America's Fentanyl Crisis


American Policy Ventures Action commends the introduction of the bipartisan FEND Off Fentanyl Act and urges passage.

WASHINGTON, May 2, 2023 /PRNewswire/ -- American Policy Ventures Action (APVA) strongly supports the Fentanyl Eradication and Narcotics Deterrence (FEND) Off Fentanyl Act. This legislation was introduced on a bipartisan basis and seeks to crack down on the fentanyl supply chain to protect American citizens from the deadly product.

Fentanyl drug overdoses are rising at an alarming rate, with more than 70,000 Americans dying from an overdose in 2021, up nearly 25 percent from the previous year. With China and Mexico remaining the primary source of fentanyl substance trafficking, sanctions are needed to target the illicit fentanyl supply chain. The FEND Off Fentanyl Act would strengthen current law and provide the Treasury Department new tools to disrupt and sanction fentanyl traffickers and money laundering operations to reduce the flow of this dangerous product into our communities.

The bill was introduced in the Senate Banking Committee by a group that includes Ranking Member Tim Scott (R-S.C.) and Chairman Sherrod Brown (D-O.H.) as well as co-sponsors from the Senate Committee on Armed Services, including Chairman Jack Reed (D-R.I.) and Ranking Member Roger Wicker (R-M.S.). APV calls on all lawmakers to rally in support of this group and advance this critical piece of legislation.

APVA Co-President and Co-Founder Paolo Mastrangelo explains, "The fentanyl crisis in the United States is too important an issue to fall victim to partisan bickering. Americans want decisive action on this emergency, and lawmakers must come together to deliver with the FEND Off Fentanyl Act. It's time to put policy over politics and forge ahead on this bipartisan solution."

About APV:

American Policy Ventures Action is a 501(c)4 advocacy organization that actively works to support members of Congress working to find bipartisan solutions to our nation's most pressing issues.

SOURCE American Policy Ventures


These press releases may also interest you

at 18:12
Functional Food Ingredients Market size is set to grow by USD 53.14 bn from 2024-2028, increased demand for functional food ingredients from probiotics segment to boost the market growth, Technavio
The global functional food ingredients market size is estimated to grow by USD 53.14 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 7.38% during the forecast period. ...

at 17:55
City of Hope Awarded $5.4 Million CIRM Grant to Create a Stem Cell Laboratory and Expand Access to State-of-the-Art Disease Models and Technology Among a Diverse Scientific Community
City of Hope®, one of the largest cancer research and treatment organizations in the United States, has been awarded $5.4 million from the California Institute for Regenerative Medicine (CIRM) to build and fund a stem cell research laboratory on its...

at 17:25
Talphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Talphera, Inc. , ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that the Board of Directors of Talphera has granted...

at 16:56
JDRF-Authored Paper Shows Pathway to Accelerate Disease-Modifying Therapies for People with Type 1 Diabetes
A paper published in the June edition of the Journal Diabetes demonstrates that C-peptide, a biomarker that indicates the production of insulin, is a validated surrogate endpoint, or predictor of clinical benefit, for clinical trials of...

at 16:28
Insmed Presents Positive Patient-Reported Outcomes and Microbiologic Data from Phase 3 ARISE Study Of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with NTM Lung Disease Caused by MAC at American Thoracic Society 2024 International Conference Plenary Session
?Patients Treated with ARIKAYCE Plus Macrolide-Based Background Regimen Had Meaningfully Greater Improvements in Respiratory Symptoms vs. Macrolide-Based Background Regimen Alone, As Measured By the QOL-B Respiratory Domain Instrument? ?QOL-B...

at 16:20
TOP-RANKED HEALTHCARE CONSULTING FIRM EXPANDS ROSTER, DEEPENS LEADERSHIP
Jarrard Inc., a leading national healthcare strategic communications consultancy, has expanded by 10 percent, adding seven new professionals to address the increasing demand for its healthcare advisory services. The team now includes 81 full-time...

More news about Health...


News published on and distributed by: